Conversion from Aranesp® to NESP® in dialysis patients-Exploration of dosing strategies and the feasibility of extending the dosing interval.

Maggie M Y MokLorraine P Y KwanGary C W ChanMaggie K M MaAngela Y M WangDesmond Y H YapCindy B Y ChoySydney Chi-Wai Tang Tak Mao Chan

Published in: Nephrology (Carlton, Vic.) (2021)

Dialysis patients on Aranesp® can be successfully converted to NESP® and the dosing interval can be extended successfully in a significant proportion of patients, which could reduce discomfort and drug cost.

Keyphrases

end stage renal disease
chronic kidney disease
peritoneal dialysis
newly diagnosed
ejection fraction
emergency department